Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Shu-long Wang"'
Publikováno v:
Linchuang shenzangbing zazhi, Vol 23, Iss 11, Pp 897-902 (2023)
Objective To explore the risk factors for new-onset glucose abnormalities in patients of idiopathic membranous nephropathy (IMN) on glucocorticoid plus tacrolimus. Methods From August 2019 to January 2022, 118 patients with a diagnosis of IMN via ren
Externí odkaz:
https://doaj.org/article/afd6047839b14f10b28b5095fc48d93a
Publikováno v:
International Journal of Ophthalmology, Vol 8, Iss 1, Pp 46-51 (2015)
AIM: To investigate into the potential involvement of pyrin containing 3 gene (NLRP3), a member of the nucleotide-binding oligomerization domain-like receptors with cytosolic pattern recognition, in the host defense of corneas against viruses. METHO
Externí odkaz:
https://doaj.org/article/07a776636a804b5c86be677917d90068
Publikováno v:
Medical Data Mining. 2024, Vol. 7 Issue 3, p1-9. 9p.
Publikováno v:
Computer Networks. 227:109715
Autor:
Shu-Hua Zhang, Jiao-Lan Qin, Shu-Long Wang, Qi-Pin Qin, Dong-Mei Luo, Ming-Xiong Tan, Zhen-Feng Wang, Bi-Qun Zou
Publikováno v:
Inorganic Chemistry Communications. 104:27-30
Two new Pt(II) complexes with sorafenib (SRFN) and regorafenib (RGFN), having the general formulae [Pt(SRFN)(DMSO)Cl2] (SRFN-Pt) and [Pt(RGFN)(DMSO)Cl2] (RGFN-Pt), were prepared and characterized by ESI-MS, IR, UV–Vis spectroscopy, elemental analys
Autor:
Ming-Xiong Tan, Hong Liang, Peng-Fei Yao, Shu-Long Wang, Bi-Qun Zou, Zhen-Feng Wang, Dong-Mei Luo, Qi-Pin Qin
Publikováno v:
European Journal of Medicinal Chemistry. 170:195-202
Herein, we report the design and synthesis of three novel binuclear platinum(II) complexes, [Pt(tpbtpy)Cl][Pt(DMSO)Cl3] (tpbtpy-Pt), [Pt(dthbtpy)Cl][Pt(DMSO)Cl3]⋅CH3OH (dthbtpy-Pt), and [Pt(qlbtpy)Cl][Pt(DMSO)Cl3]⋅CH3OH (qlbtpy-Pt) with 4′-(3-t
Autor:
Zhen-Feng Wang, Bi-Qun Zou, Qing-Min Wei, Shu-Long Wang, Hong Liang, Ming-Xiong Tan, Qi-Pin Qin, Peng-Fei Yao
Publikováno v:
Inorganic Chemistry Communications. 102:180-184
Two rhodium(III) and iron(III) complexes of 4′-(3-thiophenecarboxaldehyde)-2,2′:6′,2″-terpyridine (tpatpy): [Rh(tpatpy)Cl3]·CH3OH (tpatpy-Rh) and [Fe(tpatpy)Cl3] (tpatpy-Fe) have been prepared and characterized. Tpatpy-Rh (5.03 ± 1.15 μM)
Autor:
Bi-Qun Zou, Qi-Pin Qin, Shu-Long Wang, Dong-Mei Luo, Zhen-Feng Wang, Ming-Xiong Tan, Yan-Cheng Liu
Publikováno v:
Inorganic Chemistry Communications. 99:77-81
In the present study, one novel Pt(II) complex, [Pt(CTD)(DMSO)Cl2] (1) with 9‑chloro‑5,6,7,8‑tetrahydroacridine (CTD) as ligand, was synthesized and fully characterized. The CTD Pt(II) complex 1 was an anti-cancer drug candidate, and it possess
Autor:
Zhen-Feng Wang, Qing-Min Wei, Qi-Pin Qin, Xue-Yu Wu, Ming-Xiong Tan, Bi-Qun Zou, Dong-Mei Luo, Yan-Cheng Liu, Shu-Long Wang
Publikováno v:
Polyhedron. 157:219-224
Two new Pt(II) and Ru(II) complexes, [Pt(BFCY)Cl2] (1) and [RuCl2(BMCY)(DMSO)] (2) with 3-(1H-benzoimidazol-2-yl)-8-fluoro-chromen-2-ylideneamine (BFCY) and 3-(1H-benzoimidazol-2-yl)-8-methyl-chromen-2-ylideneamine (BMCY), were synthesized. The BFCY
Autor:
Yan-Cheng Liu, Peng-Fei Yao, Ming-Xiong Tan, Dong-Mei Luo, Bi-Qun Zou, Hong Liang, Qi-Pin Qin, Zhen-Feng Wang, Shu-Long Wang
Publikováno v:
European Journal of Medicinal Chemistry. 158:106-122
In this work, we designed and synthesized tacrine platinum(II) complexes [PtClL(DMSO)]⋅CH3OH (Pt1), [PtClL(DMP)] (Pt2), [PtClL(DPPTH)] (Pt3), [PtClL(PTH)] (Pt4), [PtClL(PIPTH)] (Pt5), [PtClL(PM)] (Pt6) and [PtClL(en)] (Pt7) with 4,4′-dimethyl-2,2